This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignee: Omega Biopharma (i.p.3) Limited. Active years: 2008-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2013
Title: Gary Kwan Po Wong: Innovator in Metabolic Modulation
Introduction
Gary Kwan Po Wong is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of biotechnology, particularly in the area of metabolic modulation. With a total of 5 patents to his name, Wong's work focuses on innovative methods to treat various biological conditions.
Latest Patents
Wong's latest patents include groundbreaking inventions aimed at modulating metabolism. One notable patent is titled "Methods for Modulating Metabolism," which provides materials and methods for addressing biological conditions associated with metabolic factors. This invention highlights the administration of a cysteamine compound to treat hypercholesterolemia and its complications. Another significant patent is "Methods for Treating Diabetes," which outlines compositions and methods for treating diabetes in patients. This invention emphasizes the concurrent administration of cysteamine hydrochloride with Metformin to effectively regulate glucose metabolism and insulin sensitivity in diabetic patients.
Career Highlights
Gary Wong is currently associated with Omega Biopharma (I.P.3) Limited, where he continues to advance his research and development efforts. His work has garnered attention for its potential to improve the quality of life for individuals suffering from metabolic disorders.
Collaborations
Wong collaborates with notable colleagues in his field, including Bill Piu Chan and Jinxian Xu. Their combined expertise contributes to the innovative research and development at Omega Biopharma.
Conclusion
Gary Kwan Po Wong stands out as a key figure in the field of metabolic modulation, with his patents paving the way for new treatments for diabetes and hypercholesterolemia. His contributions are vital to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile